Roquefort Therapeutics returns to the market with new study data
News release
by
Roquefort Therapeutics PLC
London, UK
|
June 16, 2023 06:10 AM Eastern Daylight Time
Roquefort Therapeutics PLC (LSE:ROQ, OTCQB:ROQAF) chief executive Ajan Reginald speaks to Thomas Warner from Proactive after the biotech company announced that it had achieved 'significant results' in laboratory studies involving its anti-cancer mRNA treatment. Reginald reveals more information about the study and addresses the return of Roquefort shares to the market after a delayed audit prompted a temporary suspension.
Contact Details
Proactive UK Ltd
+44 20 7989 0813
